Cristina Carvalho Barrias

Cristina Carvalho Barrias


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Acta Biomaterialia
Verified
Journal Article
Closed access
Sílvia J. BidarraSílvia J. Bidarra
Sílvia J. Bidarra
CBCristina Carvalho Barrias
Cristina Carvalho Barrias
Pedro GranjaPedro Granja
Pedro Granja

5 April 2013 in Nanomedicine
Verified
Journal Article
Closed access
Rúben PereiraRúben Pereira
Rúben Pereira
CBCristina Carvalho Barrias
Cristina Carvalho Barrias
Pedro GranjaPedro Granja
Pedro Granja
Paulo BartoloPaulo Bartolo
Paulo Bartolo
Skin is the largest organ of human body, acting as a barrier with protective, immunologic and sensorial functions. Its permanent exposure to the external environment can result in different kinds of damage with loss of variable volumes of extracellular matrix. For the treatment of skin lesions, several strategies are currently available, such as the application of autografts, allografts, wound dressings and tissue-engineered substitutes. Although proven clinically effective, these strategies are still characterized by key limitations such as patient morbidity, inadequate vascularization, low adherence to the wound bed, the inability to reproduce skin appendages and high manufacturing costs. Advanced strategies based on both bottom-up and top-down approaches offer an effective, permanent and viable alternative to solve the abovementioned drawbacks by combining biomaterials, cells, growth factors and advanced biomanufacturing techniques. This review details recent advances in skin regeneration and repair strategies, and describes their major advantages and limitations. Future prospects for skin regeneration are also outlined.

1 August 2004 in Biomaterials
Verified
Journal Article
Closed access
CRC.C Ribeiro
C.C Ribeiro
CBCristina Carvalho Barrias
Cristina Carvalho Barrias
MBM.A Barbosa
M.A Barbosa

30 June 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
MNMariana I Neves
Mariana I Neves
Lorenzo MoroniLorenzo Moroni
Lorenzo Moroni
CBCristina Carvalho Barrias
Cristina Carvalho Barrias
The rational choice and design of biomaterials for biomedical applications is crucial for successful in vitro and in vivo strategies, ultimately dictating their performance and potential clinical applications. Alginate, a marine-derived polysaccharide obtained from seaweeds, is one of the most widely used polymers in the biomedical field, particularly to build three dimensional (3D) systems for in vitro culture and in vivo delivery of cells. Despite their biocompatibility, alginate hydrogels often require modifications to improve their biological activity, namely via inclusion of mammalian cell-interactive domains and fine-tuning of mechanical properties. These modifications enable the addition of new features for greater versatility and control over alginate-based systems, extending the plethora of applications and procedures where they can be used. Additionally, hybrid systems based on alginate combination with other components can also be explored to improve the mimicry of extracellular microenvironments and their dynamics. This review provides an overview on alginate properties and current clinical applications, along with different strategies that have been reported to improve alginate hydrogels performance as 3D matrices and 4D dynamic systems.


1 November 2011 in Biomaterials
Verified
Journal Article
Closed access
Sílvia J. BidarraSílvia J. Bidarra
Sílvia J. Bidarra
CBCristina Carvalho Barrias
Cristina Carvalho Barrias
KFKeila B. Fonseca
Keila B. Fonseca
MBMário A. Barbosa
Mário A. Barbosa
Raquel SoaresRaquel Soares
Raquel Soares
Pedro GranjaPedro Granja
Pedro Granja